Загрузка...
Modulation of Determinant Factors to Improve Therapeutic Combinations with Immune Checkpoint Inhibitors
Immune checkpoint inhibitors (ICPi) have shown their superiority over conventional therapies to treat some cancers. ICPi are effective against immunogenic tumors. However, patients with tumors poorly infiltrated with immune cells do not respond to ICPi. Combining ICPi with other anticancer therapies...
Сохранить в:
| Опубликовано в: : | Cells |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7408477/ https://ncbi.nlm.nih.gov/pubmed/32707692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9071727 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|